BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22798315)

  • 1. A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.
    Tu L; De Man FS; Girerd B; Huertas A; Chaumais MC; Lecerf F; François C; Perros F; Dorfmüller P; Fadel E; Montani D; Eddahibi S; Humbert M; Guignabert C
    Am J Respir Crit Care Med; 2012 Oct; 186(7):666-76. PubMed ID: 22798315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beneficial effect of suramin on monocrotaline-induced pulmonary hypertension in rats.
    Izikki M; Mercier O; Lecerf F; Guin LL; Hoang E; Dorfmüller P; Perros F; Humbert M; Simonneau G; Dartevelle P; Fadel E; Eddahibi S
    PLoS One; 2013; 8(10):e77073. PubMed ID: 24143201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central role of ubiquitin-specific protease 8 in leptin signaling pathway in pulmonary arterial hypertension.
    Jutant EM; Chelgham MK; Ottaviani M; Thuillet R; Le Vely B; Humbert M; Guignabert C; Tu L; Huertas A
    J Heart Lung Transplant; 2024 Jan; 43(1):120-133. PubMed ID: 37704159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.
    Ghofrani HA; Morrell NW; Hoeper MM; Olschewski H; Peacock AJ; Barst RJ; Shapiro S; Golpon H; Toshner M; Grimminger F; Pascoe S
    Am J Respir Crit Care Med; 2010 Nov; 182(9):1171-7. PubMed ID: 20581169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F1 Mediates SOX17 Deficiency-Induced Pulmonary Hypertension.
    Yi D; Liu B; Ding H; Li S; Li R; Pan J; Ramirez K; Xia X; Kala M; Ye Q; Lee WH; Frye RE; Wang T; Zhao Y; Knox KS; Glembotski CC; Fallon MB; Dai Z
    Hypertension; 2023 Nov; 80(11):2357-2371. PubMed ID: 37737027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible or irreversible remodeling in pulmonary arterial hypertension.
    Sakao S; Tatsumi K; Voelkel NF
    Am J Respir Cell Mol Biol; 2010 Dec; 43(6):629-34. PubMed ID: 20008280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery.
    Xu H; Ji H; Li Z; Qiao W; Wang C; Tang J
    Int J Nanomedicine; 2021; 16():1221-1229. PubMed ID: 33628019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating the dysregulated migration of pulmonary arterial hypertensive smooth muscle cells with motif mimicking cell permeable peptides.
    Wilson JL; Rupasinghe C; Usheva A; Warburton R; Kaplan C; Taylor L; Hill N; Mierke DF; Polgar P
    Curr Top Pept Protein Res; 2015; 16():1-17. PubMed ID: 27274622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial platelet-derived growth factor-mediated activation of smooth muscle platelet-derived growth factor receptors in pulmonary arterial hypertension.
    Wu K; Tang H; Lin R; Carr SG; Wang Z; Babicheva A; Ayon RJ; Jain PP; Xiong M; Rodriguez M; Rahimi S; Balistrieri F; Rahimi S; Valdez-Jasso D; Simonson TS; Desai AA; Garcia JGN; Shyy JY; Thistlethwaite PA; Wang J; Makino A; Yuan JX
    Pulm Circ; 2020; 10(3):2045894020948470. PubMed ID: 33294172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension.
    Piper B; Bogamuwa S; Hossain T; Farkas D; Rosas L; Green AC; Newcomb G; Sun N; Ovando-Ricardez JA; Horowitz JC; Bhagwani AR; Yang H; Kudryashova TV; Rojas M; Mora AL; Yan P; Mallampalli RK; Goncharova EA; Eckmann DM; Farkas L
    J Clin Invest; 2024 Feb; 134(3):. PubMed ID: 38015641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.
    Le Hiress M; Tu L; Ricard N; Phan C; Thuillet R; Fadel E; Dorfmüller P; Montani D; de Man F; Humbert M; Huertas A; Guignabert C
    Am J Respir Crit Care Med; 2015 Oct; 192(8):983-97. PubMed ID: 26203495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension.
    Ricard N; Tu L; Le Hiress M; Huertas A; Phan C; Thuillet R; Sattler C; Fadel E; Seferian A; Montani D; Dorfmüller P; Humbert M; Guignabert C
    Circulation; 2014 Apr; 129(15):1586-97. PubMed ID: 24481949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factors and potential therapeutic targets for pulmonary hypertension.
    Yang L; Wan N; Gong F; Wang X; Feng L; Liu G
    Front Cell Dev Biol; 2023; 11():1132060. PubMed ID: 37009479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells.
    Xiong Y; Wang Y; Yang T; Luo Y; Xu S; Li L
    Am J Cardiovasc Drugs; 2023 Sep; 23(5):497-518. PubMed ID: 37524956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Vascular Remodeling in Pulmonary Hypertension.
    Jia Z; Wang S; Yan H; Cao Y; Zhang X; Wang L; Zhang Z; Lin S; Wang X; Mao J
    J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis.
    Sanges S; Rice L; Tu L; Valenzi E; Cracowski JL; Montani D; Mantero JC; Ternynck C; Marot G; Bujor AM; Hachulla E; Launay D; Humbert M; Guignabert C; Lafyatis R
    Ann Rheum Dis; 2023 Mar; 82(3):365-373. PubMed ID: 36600187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic reprogramming: A novel metabolic model for pulmonary hypertension.
    Liu X; Zhang L; Zhang W
    Front Cardiovasc Med; 2022; 9():957524. PubMed ID: 36093148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic pulmonary endothelial cells release epidermal growth factor leading to vascular smooth muscle cell arginase-2 expression and proliferation.
    Chen B; Jin Y; Pool CM; Liu Y; Nelin LD
    Physiol Rep; 2022 Jun; 10(11):e15342. PubMed ID: 35674115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
    Mohamed NA; Marei I; Crovella S; Abou-Saleh H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension.
    Pal-Ghosh R; Xue D; Warburton R; Hill N; Polgar P; Wilson JL
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.